Amgen ($AMGN) has provided further evidence that its $415 million bet on deCode Genetics’ trove of genomic data can pay off. The latest validation of the deal ...
Scientists at deCODE genetics—a subsidiary of Amgen—together with collaborators from Denmark report on the whole genome sequences of 150 thousand participants in the UK biobank in a paper published in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results